# APTR

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aptr

- Industry: Electronics
- Headquarters: Shanghai, China
- Website: www.aptr.com.cn
- Total disclosed funding: $143M
- Latest round: Series B (Dec 26, 2025)
- Investors on record: 10

## About

Founded in 2020 in Shanghai, China, Shanghai APTR Particle Equipment Co., Ltd., trading as APTR specializes in proton therapy systems, providing tailored solutions for healthcare facilities. In December 2025, APTR raised approximately CNY 1 billion in Series B funding co-led by new investors New Alliance Capital, Cenova Ventures, Shanghai STVC Group, China Pacific Insurance (Group), Fortera Capital, with participation from new investors Shanghai Information Investment Inc, Atlas Shanghai, Finewill Capital, Shanghai Xuhui Technology Venture Capital, Shanghai Jiading Industrial Zone Development (Group) Co., Ltd. and other unspecified investors.
APTR specializes in the development and provision of proton therapy systems for cancer treatment. Its offerings include comprehensive solutions for proton treatment centers, designed to meet the specific needs of hospitals and enhance precision in targeting tumor cells while minimizing damage to surrounding healthy tissue. APTR's products are primarily sold to hospitals and medical institutions in metropolitan areas of China, contributing to the improvement of cancer care.
The company's revenue is driven primarily through direct sales of its proton therapy systems to healthcare providers, characterized by significant one-time transaction values. Revenue structures often include installation, technical training, and ongoing support services to ensure comprehensive assistance for healthcare partners.

## Funding rounds

- Series B, Dec 26, 2025, $143M — Shanghai STVC Group, China Pacific Insurance (Group), Shanghai Xuhui Technology Venture Capital, Cenova Ventures, New Alliance Capital, Atlas Shanghai, Shanghai Information Investment Inc., Finewill Capital, Shanghai Jiading Industrial Zone Development (Group) Co., Ltd., Fortera Capital

## Investors

- Shanghai STVC Group (https://capitalatlas.ai/funds/shanghai-stvc-group) — Series B
- China Pacific Insurance (Group) — Series B
- Shanghai Xuhui Technology Venture Capital — Series B
- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series B
- New Alliance Capital (https://capitalatlas.ai/funds/new-alliance-capital) — Series B
- Atlas Shanghai (https://capitalatlas.ai/funds/atlas-shanghai) — Series B
- Shanghai Information Investment Inc. — Series B
- Finewill Capital (https://capitalatlas.ai/funds/finewill-capital) — Series B
- Shanghai Jiading Industrial Zone Development (Group) Co., Ltd. — Series B
- Fortera Capital (https://capitalatlas.ai/funds/fortera-capital) — Series B